(Q36436880)

14 August 2017

1 reference

title

The molecular action of tumor necrosis factor-alpha (English)

1 reference

14 August 2017

F Bussolino

4

0 references

Giovanni Camussi

object named as

G Camussi

series ordinal

1

0 references

author name string

E Albano

series ordinal

2

1 reference

14 August 2017

C Tetta

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

14 August 2017

1 reference

14 August 2017

volume

202

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

3-14

1 reference

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-kappa B-like factor to a promoter element

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Antiviral effects of recombinant tumour necrosis factor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Recent insights in phosphatidylinositol signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

A tumour promoter, 12-O-tetradecanoylphorbol 13-acetate, increases cellular 1,2-diacylglycerol content through a mechanism other than phosphoinositide hydrolysis in Swiss-mouse 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Mechanism of production of toxic oxygen radicals by granulocytes and macrophages and their function in the inflammatory process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Role of metals in oxygen radical reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Oxidative injury and the heat shock response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

A novel tumor necrosis factor-responsive transcription factor which recognizes a regulatory element in hemopoietic growth factor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1991.TB16337.X

Identification of an inducible endothelial-leukocyte adhesion molecule

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.84.24.9238

Identifiers

DOI

10.1111/J.1432-1033.1991.TB16337.X

1 reference

14 August 2017

1 reference